Moderate to severe disease activity was numerically associated with greater polypharmacy; however, this did not reach statistical significance ( P = 0.09).
← all excerpts
Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease.
1
0.0900
0.0900